scispace - formally typeset
L

Lene Uhrbom

Researcher at Science for Life Laboratory

Publications -  65
Citations -  3348

Lene Uhrbom is an academic researcher from Science for Life Laboratory. The author has contributed to research in topics: Glioma & Stem cell. The author has an hindex of 29, co-authored 59 publications receiving 2967 citations. Previous affiliations of Lene Uhrbom include Memorial Sloan Kettering Cancer Center & Uppsala University.

Papers
More filters
Journal Article

Induction of Brain Tumors in Mice Using a Recombinant Platelet-derived Growth Factor B-Chain Retrovirus

TL;DR: The results show that an autocrine mechanism of transformation may be an initial or early event in neuro-oncogenesis, and the present model provides an ideal system for studies of genetic mechanisms involved in the development of brain tumors.
Journal Article

Ink4a-Arf Loss Cooperates with KRas Activation in Astrocytes and Neural Progenitors to Generate Glioblastomas of Various Morphologies Depending on Activated Akt

TL;DR: It is shown here that Ink4a-Arf deficiency allows for GBM formation from astrocytes and that it enhances tumor incidence in neural progenitor cells, and this data strongly supports the view that one role of loss of Ink4o-ARF in gliomagenesis could be to sensitize astroCytes to transformation through dedifferentiation in response to the appropriate oncogenic stimuli.
Journal ArticleDOI

The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes

TL;DR: This work developed a library of annotated and validated cell lines derived from surgical samples of GBM patients, maintained under conditions to preserve GSC characteristics, and demonstrates that the HGCC lines are tumorigenic, harbor genomic lesions characteristic of GBMs, and represent all four transcriptional subtypes.
Journal ArticleDOI

Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.

TL;DR: It is shown that the cell of origin for glioma may be a committed glial progenitor cell, and platelet-derived growth factor B transfer to OPCs could induce gliomas with an incidence of 33%.